Understanding a tumor’s genomics is becoming more critical in cancer care. Patients who have a certain mutation or rearrangement may benefit from some of the targeted therapies that the Food and Drug ...

Giovanna Whitting received selpercatinib to treat her thyroid cancer as part of a clinical trial when she was 16 years old. Today, she is a healthy, happy college student. “Selpercatinib has shown a ...

Eli Lilly has axed its next-generation RET inhibitor. The Big Pharma pushed the candidate, LOXO-260, into the clinic to overcome acquired resistance to existing drugs such as its own Retevmo but has ...

Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients. Trastuzumab deruxtecan (T-DXd) in patients with human epidermal ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat ...

PARK CITY, Utah--(BUSINESS WIRE)--RET Ventures, an industry-backed venture capital firm focused on technologies for the multifamily, single-family rental (SFR), homebuilding and broader real estate ...

Products Market Alerts MyCollection Price Database Become a Partner Gallery ...